|
|
Neural Therapeutics Inc
CSE •
Healthcare •
Biotechnology •
Quote as of 11/11/2026 14:22
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeCSE
Market Capitalization1.69 mln
Earnings Date11/20/2026
Key Fundamentals
EPS-0.01
ROIC-84.89
ROA-135
EBITDA, mln-0.97
EV / EBITDA-2.94
EV / EBIT-2.94
Quote Details
Last
0.005
Change
-0.005 (-50%)
Open
0.005
Volume
2,151,373
Turnover
10,757
Average Volume
178,064
Financial Ratios
Current Ratio0.39
Price / Book3.33
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-50% |
0
/ 100
 |
| 1 Month |
-75% |
0
/ 100
|
| 2 Months |
-66.67% |
4
/ 100
|
| 6 Months |
-66.67% |
36
/ 100
 |
| 1 Year |
-85.71% |
19
/ 100
 |
|
| |
